We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$201M
AUM Growth
+$21.6M
Cap. Flow
+$4.01M
Cap. Flow %
2%
Top 10 Hldgs %
34.54%
Holding
94
New
3
Increased
25
Reduced
34
Closed
3

Top Buys

Rank Stock Value
1
EPZM
Epizyme, Inc
EPZM
+$1.45M
2
QCOM icon
Qualcomm
QCOM
+$1.25M
3
GSK icon
GSK
GSK
+$958K
4
JCI icon
Johnson Controls International
JCI
+$689K
5
SLB icon
SLB Ltd
SLB
+$507K

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$720K
2
DVN icon
Devon Energy
DVN
+$514K
3
JNJ icon
Johnson & Johnson
JNJ
+$430K
4
CNI icon
Canadian National Railway
CNI
+$342K
5
PRGO icon
Perrigo
PRGO
+$341K

Sector Composition

Rank Sector Weight
1 Healthcare 22.57%
2 Industrials 18.92%
3 Technology 17.72%
4 Energy 14.64%
5 Consumer Staples 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPGP icon
51
IPG Photonics
IPGP
$4.16B
$957K 0.48%
12,330
+6,085
+97% +$414K
COP icon
52
ConocoPhillips
COP
$141B
$940K 0.47%
13,309
– –
XLNX
53
DELISTED
Xilinx Inc
XLNX
$867K 0.43%
18,865
+8,810
+88% +$396K
LH icon
54
Labcorp
LH
$23.1B
$862K 0.43%
10,994
– –
MCD icon
55
McDonald's
MCD
$190B
$615K 0.31%
6,340
– –
ALNY icon
56
Alnylam Pharmaceuticals
ALNY
$36.4B
$606K 0.3%
9,420
-235
-2% -$14K
TT icon
57
Trane Technologies
TT
$103B
$603K 0.3%
9,786
-2,784
-22% -$153K
TGT icon
58
Target
TGT
$63.4B
$589K 0.29%
9,315
+2,715
+41% +$174K
CI icon
59
Cigna
CI
$75.1B
$567K 0.28%
6,480
– –
PFE icon
60
Pfizer
PFE
$141B
$506K 0.25%
17,423
– –
PSX icon
61
Phillips 66
PSX
$83.7B
$495K 0.25%
6,407
-21
-0.3% -$1.4K
STT icon
62
State Street
STT
$50.2B
$484K 0.24%
6,592
– –
KMB icon
63
Kimberly-Clark
KMB
$36B
$421K 0.21%
4,203
– –
NEE icon
64
NextEra Energy
NEE
$184B
$380K 0.19%
17,760
– –
BAX icon
65
Baxter International
BAX
$11.4B
$378K 0.19%
10,011
– –
CSX icon
66
CSX Corp
CSX
$93.1B
$333K 0.17%
34,800
– –
GIS icon
67
General Mills
GIS
$20.1B
$314K 0.16%
6,288
– –
TEVA icon
68
Teva Pharmaceuticals
TEVA
$36.1B
$303K 0.15%
7,565
-18,275
-71% -$720K
SJT
69
San Juan Basin Royalty Trust
SJT
$126M
$298K 0.15%
17,750
-300
-2% -$4.93K
CAT icon
70
Caterpillar
CAT
$398B
$275K 0.14%
3,024
– –
BDBD
71
DELISTED
BOULDER BRANDS INC
BDBD
$258K 0.13%
16,200
-1,720
-10% -$26.7K
T icon
72
AT&T
T
$153B
$256K 0.13%
9,632
– –
NGG icon
73
National Grid
NGG
$82B
$253K 0.13%
4,017
– –
APC
74
DELISTED
Anadarko Petroleum
APC
$241K 0.12%
3,040
– –
LLY icon
75
Eli Lilly
LLY
$1.02T
$240K 0.12%
4,700
– –
1 2
3
4

Similar funds

MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
GPWA
Great Point Wealth Advisors Boston, Massachusetts $542M AUM
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return

Brian C. Broderick's Q4 2013 Portfolio in Review

As of Q4 2013, Brian C. Broderick held 94 positions worth $201M, up 12% from $179M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Brian C. Broderick's Q4 2013 filing shows 3 new, 25 increased, 34 reduced and 3 closed positions. Its largest new stake was Epizyme, Inc: 50,000 shares worth $1.04M. The largest sale was Teva Pharmaceuticals, an estimated $720K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Brian C. Broderick's largest Q4 2013 buy was Epizyme, Inc: 50,000 shares worth $1.04M.
  • Brian C. Broderick added most to Qualcomm in Q4 2013, an estimated $1.25M increase.
  • Brian C. Broderick's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $720K.
  • Brian C. Broderick fully exited Devon Energy in Q4 2013, selling an estimated $514K.
  • Brian C. Broderick's ten largest holdings make up 35% of its $201M portfolio in Q4 2013.
  • Brian C. Broderick opened 3 new positions and closed 3 in Q4 2013.
  • Brian C. Broderick's portfolio value rose 12% quarter-over-quarter to $201M.

Based on Brian C. Broderick's 13F filing for Q4 2013, filed 27 Feb 2014.